Olink Holding AB (publ) (OLK) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Diagnostics & Research 산업에서 운영. 본사 소재지는 Uppsala, Sweden. 현재 CEO는 Jon Heimer.
OLK 을(를) 보유 IPO 날짜 2021-03-26, 707 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $3.24B.
Olink Holding AB (publ) is a Swedish life sciences company founded in 2004 and headquartered in Uppsala that provides protein analysis products and services to academic institutions, government agencies, and biopharmaceutical and biotechnology companies. The company's platform includes Olink Explore for disease-specific research areas such as cardiovascular, metabolic, oncology, and neurology applications, along with customizable Olink Target and Olink Focus product lines. Olink offers comprehensive solutions spanning assay execution through its Olink Signature Q100 platform, analytical services including study design and data processing, and software tools such as NPX Manager and Olink Insight for data visualization and statistical analysis. The company operates a direct sales organization across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions to serve its global customer base.
